Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/37082
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBATEN, Evert-
dc.contributor.authorVan der Aa, F.-
dc.contributor.authorGOETHUYS, Hans-
dc.contributor.authorSlabbaert, K.-
dc.contributor.authorARIJS, Ingrid-
dc.contributor.authorVAN RENTERGHEM, Koenraad-
dc.date.accessioned2022-03-30T09:16:16Z-
dc.date.available2022-03-30T09:16:16Z-
dc.date.issued2021-
dc.date.submitted2022-03-25T10:26:48Z-
dc.identifier.citationJOURNAL OF UROLOGY, 205 (6) , p. 1748 -1752-
dc.identifier.urihttp://hdl.handle.net/1942/37082-
dc.description.abstractPurpose: We sought to determine whether omitting antimicrobial prophylaxis is safe in patients undergoing transurethral resection of the prostate without preoperative pyuria and a preoperative catheter. Materials and Methods: We conducted a multicenter randomized controlled trial from September 17, 2017 until December 31, 2019 in 5 hospitals. Patients with pyuria (>100 white blood cells/ml) and a preoperative indwelling catheter were excluded. Postoperative fever was defined as a body temperature >= 38.3C. A noninferiority design was used with a 6% noninferiority margin and null hypothesis (H0) that the infection risk is at least 6% higher in the experimental (E) than in the control (C) group; H0: C (antimicrobial prophylaxis group) - E (no antimicrobial prophylaxis group) >=Delta (6% noninferiority margin). A multivariable, logistic regression was performed regarding posttransurethral resection of the prostate fever and antimicrobial prophylaxis with co-variates: (clot-)retention and operating time. The R Project (R) for statistical computing was used and a p value of 0.05 was considered as statistically significant. Results: Of the patients 474 were included for multivariable analysis and 211/ 474 (44.5%) received antimicrobial prophylaxis vs 263/474 (55.5%) patients without antimicrobial prophylaxis. Antibiotics were fluoroquinolones in 140/211 (66.4%), cephazolin in 58/211 (27.5%) and amikacin in 13/211 (6.2%) patients. Fever occurred in 9/211 (4.4%) patients with antimicrobial prophylaxis vs 13/263 (4.9%) without antimicrobial prophylaxis (p=0.8, risk difference 0.006 [95% CI -0.003-0.06, relative risk 1.16]). We were able to exclude a meaningful increase in harm associated with omitting antimicrobial prophylaxis (p=0.4; adjusted risk difference 0.016 [95% CI -0.02-0.05]). Conclusions: Our data demonstrate the safety of omitting antimicrobial prophylaxis in patients undergoing transurethral resection of the prostate without preoperative pyuria and a preoperative indwelling catheter.-
dc.language.isoen-
dc.publisherLIPPINCOTT WILLIAMS & WILKINS-
dc.rights2021 by American Urological Association Education and Research, Inc.-
dc.subject.othertransurethral resection of prostate-
dc.subject.otherrandomized controlled trial-
dc.subject.otherfever-
dc.subject.otherdrug resistance-
dc.subject.othermicrobialantibiotic prophylaxis-
dc.titleAntimicrobial Prophylaxis in Transurethral Resection of the Prostate: Results of a Randomized Trial-
dc.typeJournal Contribution-
dc.identifier.epage1752-
dc.identifier.issue6-
dc.identifier.spage1748-
dc.identifier.volume205-
local.format.pages5-
local.bibliographicCitation.jcatA1-
dc.description.notesBaten, E (corresponding author), AZ Diest UHasselt, Associatie Urol Hageland RZ Tienen, Kapellekensweg 10, Kessel Lo, Belgium.-
dc.description.notesEvert.baten@gmail.com-
local.publisher.placeTWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA-
local.type.refereedRefereed-
local.type.specifiedArticle-
dc.identifier.doi10.1097/JU.0000000000001638-
dc.identifier.isiWOS:000760589000043-
local.provider.typewosris-
local.description.affiliation[Baten, E.; Slabbaert, K.] Associatie Urol Hageland, Tielt Winge, Belgium.-
local.description.affiliation[Van der Aa, F.; van Renterghem, K.] Univ Hosp Leuven, Dept Urol, Leuven, Belgium.-
local.description.affiliation[Goethuys, H.] Ziekenhuis Oost Limburg, Genk, Belgium.-
local.description.affiliation[Arijs, I; van Renterghem, K.] Ctr Canc Biol, Leuven, Belgium.-
local.description.affiliation[Baten, E.; van Renterghem, K.] Univ Hasselt, Hasselt, Belgium.-
local.description.affiliation[van Renterghem, K.] Jessa Ziekenhuis, Dient Urol, Hasselt, Belgium.-
local.uhasselt.internationalno-
item.accessRightsClosed Access-
item.validationecoom 2023-
item.fulltextNo Fulltext-
item.fullcitationBATEN, Evert; Van der Aa, F.; GOETHUYS, Hans; Slabbaert, K.; ARIJS, Ingrid & VAN RENTERGHEM, Koenraad (2021) Antimicrobial Prophylaxis in Transurethral Resection of the Prostate: Results of a Randomized Trial. In: JOURNAL OF UROLOGY, 205 (6) , p. 1748 -1752.-
item.contributorBATEN, Evert-
item.contributorVan der Aa, F.-
item.contributorGOETHUYS, Hans-
item.contributorSlabbaert, K.-
item.contributorARIJS, Ingrid-
item.contributorVAN RENTERGHEM, Koenraad-
crisitem.journal.issn0022-5347-
crisitem.journal.eissn1527-3792-
Appears in Collections:Research publications
Show simple item record

WEB OF SCIENCETM
Citations

2
checked on Apr 24, 2024

Page view(s)

54
checked on Jun 16, 2023

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.